Literature DB >> 24006127

Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.

Tomohiro Maniwa1, Masahiro Endo, Mitsuhiro Isaka, Kazuo Nakagawa, Yasuhisa Ohde, Takehiro Okumura, Haruhiko Kondo.   

Abstract

PURPOSE: Interstitial lung disease (ILD) has been associated with primary lung cancer and an increased risk of postoperative acute exacerbation (AE). The effectiveness of 2-[18]-fluoro-2-deoxy-D-glucose ((18)F-FDG) positron emission tomography (PET) for staging lung cancer is well established. This study investigates the association of FDG uptake on PET in patients with AE of ILD.
METHODS: The subjects of this retrospective study were 1309 patients with lung cancer, who underwent pulmonary resection at Shizuoka Cancer Center between September, 2002 and January, 2011. ILD was diagnosed with chest computed tomography in 95 patients, 81 of whom underwent (18)F-FDG PET before surgery. Six patients suffered from AE after surgery (AE group), while the remaining 75 (non-AE group) did not. We investigated the clinico-pathological findings and the results of FDG uptake on PET using the value of the I/M ratio, which is the ratio of the peak of standardized uptake value (SUV) of the ILD area to the mean SUV of the mediastinum.
RESULTS: There was no significant difference in clinico-pathological findings, but a significance difference in the I/M ratio (P = 0.0102).
CONCLUSION: The FDG uptake in PET may be a predictive factor for AE of ILD in patients who have undergone lung cancer surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006127     DOI: 10.1007/s00595-013-0711-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

1.  Acute exacerbation of idiopathic pulmonary fibrosis: report of a series.

Authors:  V Ambrosini; A Cancellieri; M Chilosi; M Zompatori; R Trisolini; L Saragoni; V Poletti
Journal:  Eur Respir J       Date:  2003-11       Impact factor: 16.671

2.  Pulmonary vascular permeability in interstitial lung disease. A positron emission tomographic study.

Authors:  J D Kaplan; E P Trulock; D J Anderson; D P Schuster
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  Prediction of acute pulmonary complications after resection of lung cancer in patients with preexisting interstitial lung disease.

Authors:  J S Park; H K Kim; K Kim; J Kim; Y M Shim; Y S Choi
Journal:  Thorac Cardiovasc Surg       Date:  2011-04-08       Impact factor: 1.827

4.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure.

Authors:  J B Stern; H Mal; O Groussard; O Brugière; A Marceau; G Jebrak; M Fournier
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

5.  Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.

Authors:  J M Goo; J G Im; K H Do; J S Yeo; J B Seo; H Y Kim; J K Chung
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

6.  Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer.

Authors:  Yasushi Shintani; Mitsunori Ohta; Teruo Iwasaki; Naoki Ikeda; Emiko Tomita; Kunimitsu Kawahara; Yuko Ohno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

7.  Positron emission tomography in interstitial lung disease.

Authors:  Samir Nusair; Rina Rubinstein; Nanette M Freedman; Gail Amir; Naama R Bogot; Uzi Izhar; Raphael Breuer
Journal:  Respirology       Date:  2007-11       Impact factor: 6.424

8.  Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

Authors:  Aren van Waarde; David C P Cobben; Albert J H Suurmeijer; Bram Maas; Willem Vaalburg; Erik F J de Vries; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

9.  Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes.

Authors:  Masako Chiyo; Yasuo Sekine; Takekazu Iwata; Koichiro Tatsumi; Kazuhiro Yasufuku; Akira Iyoda; Mizuto Otsuji; Shigetoshi Yoshida; Kiyoshi Shibuya; Toshihiko Iizasa; Yukio Saitoh; Takehiko Fujisawa
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

10.  Metformin increases glucose transporter protein and gene expression in human fibroblasts.

Authors:  A Hamann; H Benecke; H Greten; S Matthaei
Journal:  Biochem Biophys Res Commun       Date:  1993-10-15       Impact factor: 3.575

View more
  3 in total

1.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.

Authors:  Takekazu Iwata; Shigetoshi Yoshida; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Tetsuzo Tagawa; Teruaki Mizobuchi; Satoshi Ota; Yukio Nakatani; Ichiro Yoshino
Journal:  Surg Today       Date:  2014-11-22       Impact factor: 2.549

2.  Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.

Authors:  Hideyuki Maeda; Masato Kanzaki; Kei Sakamoto; Tamami Isaka; Kunihiro Oyama; Masahide Murasugi; Takamasa Onuki
Journal:  Surg Today       Date:  2017-02-28       Impact factor: 2.549

3.  Risk factors for acute exacerbation of interstitial lung disease following lung cancer resection: a systematic review and meta-analysis.

Authors:  Xiaohu Hao; Jianqi Hao; Cong Chen; Haoning Peng; Jian Zhang; Qi Cao; Lunxu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.